[HTML][HTML] Double-Masked, Vehicle-Controlled, Randomized, Phase II Study of the Ocular Hypotensive Activity and Safety of VVN539 Ophthalmic Solution
D Wirta, XY Li, W Shen, C Lu, GD Novack… - Ophthalmology …, 2024 - Elsevier
Purpose To assess safety and ocular hypotensive efficacy of VVN539 ophthalmic solution in
a first-in-human study. Design Multicenter, double-masked, randomized, vehicle-controlled …
a first-in-human study. Design Multicenter, double-masked, randomized, vehicle-controlled …
[HTML][HTML] Preservative-Free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% for Treatment-Naive Patients with Open-Angle Glaucoma
T Rhee, J Kim, A Ha - Korean Journal of Ophthalmology: KJO, 2024 - ncbi.nlm.nih.gov
Purpose To assess efficacy, safety, and tolerability of the preservative-free (PF) fixed-dose
combination (FC) of tafluprost 0.0015%/timolol 0.5%(PF tafluprost/timolol FC) in treatments …
combination (FC) of tafluprost 0.0015%/timolol 0.5%(PF tafluprost/timolol FC) in treatments …